Journals / Türk Oftalmoloji Dergisi / 2014 / Cilt: 44 - Sayı: 5

Clinical findings and treatment results in ocular adnexal lymphomas

Oküler adneksal lenfomalı olgularda klinik bulgular ve tedavi sonuçları

Pages
374–378
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

EBRT is the preferred treatment in localized periorbital disease, and chemotherapy is used in cases with systemic involvement. (Turk J Ophthalmol 2014; 44: 374-8)

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: To evaluate the clinical characteristics and treatment results in patients who were diagnosed to have ocular adnexal lymphoma (OAL).
📊
Key Findings & Data:Materials and Methods: We retrospectively evaluated twenty-six patients with OAL who were diagnosed and treated in the Oncology Service, Department of Ophthalmology, Ankara University School of Medicine, between October 1998 and 2011.
💡
Conclusion & Impact:EBRT is the preferred treatment in localized periorbital disease, and chemotherapy is used in cases with systemic involvement. (Turk J Ophthalmol 2014; 44: 374-8)
🔬Design:Research Article
📍Scope:2011 Verileri
⚙️Variables:Domain Parameters

Abstract

Objectives: To evaluate the clinical characteristics and treatment results in patients who were diagnosed to have ocular adnexal lymphoma (OAL). Materials and Methods: We retrospectively evaluated twenty-six patients with OAL who were diagnosed and treated in the Oncology Service, Department of Ophthalmology, Ankara University School of Medicine, between October 1998 and 2011. Results: There were 16 women and 10 men. The mean age was 61.6 (range: 27-76) years. The tumor affected the conjunctiva in 10 patients, the orbit in 8 patients, eyelids in 3 patients, the lacrimal gland in 3 patients, the conjunctiva and the orbit in 2 patients. A diagnostic incisional biopsy or subtotal tumor excision was generally performed. Total surgical excision, if possible, was performed in some cases. Histopathologically, all the tumors were diagnosed as B cell non-Hodgkin lymphoma. External beam radiotherapy (EBRT) was given in 19 patients, and chemotherapy in three patients because of systemic involvement. Combination of EBRT and chemotherapy was given in two patients. Three patients underwent total surgical excision. Orbital recurrence was detected in one patient during the mean follow-up period of 27 months (range: 2-72 months). At the end of the follow-up period, five cases developed keratopathy secondary to radiotherapy. One patient died from intracranial lymphoma involvement. Conclusion: OALs usually have favorable prognosis with congenial treatment. EBRT is the preferred treatment in localized periorbital disease, and chemotherapy is used in cases with systemic involvement. (Turk J Ophthalmol 2014; 44: 374-8)

Özet

Amaç: Oküler adneksal lenfomalı (OAL) olgularımızda klinik özellikler ve tedavi sonuçlarımızı değerlendirmek. Gereç ve Yöntem: Ekim 1998 ve Aralık 2011 tarihleri arasında Ankara Üniversitesi Tıp Fakültesi Göz Hastalıkları Anabilim Dalı Oküler Onkoloji servisinde tanı alarak tedavi yapılan oküler adneksal lenfomalı 26 olgu retrospektif olarak değerlendirildi. Bulgular: Olguların 16sı kadın, 10u erkek olup yaş ortalaması 61,6 (27-76) idi. On olguda konjonktiva, 8 olguda orbita, 3 olguda kapak, 3 olguda lakrimal gland ve 2 olguda konjonktiva-orbita tutulumu mevcuttu. Genel olarak tanı amaçlı insizyonel biyopsi/subtotal eksizyon uygulandı. Tümörün total olarak çıkarılabildiği olgularda total eksizyon yapıldı. Histopatolojik olarak tüm olgularda B hücreli non-Hodgkin lenfoma tespit edildi. On dokuz olguda orbitaya eksternal radyoterapi verildi. Dört olguda göz dışı sistemik tutulum mevcut olduğu için kemoterapi uygulandı. Bir olguda radyoterapi sonrası izlem sürecinde sistemik tutulum nedeniyle kemoterapi verildi. Üç olguda total eksizyonel biyopsi dışında ek tedavi uygulanmadı. Ortalama 27 (2-72) aylık izlemde bir olguda orbitada nüks izlendi ve kemoterapi uygulandı. İzlem süresi sonunda beş olguda radyoterapiye bağlı keratopati izlendi. Bir olgu intrakranial tutulum sonucu ex oldu. Sonuç: OALler uygun tedavi ile iyi prognoza sahiptir. Doku tanısını takiben sadece göz çevresinde tutulum olan lenfomalarda radyoterapi, sistemik tutulum varlığında kemoterapi tercih edilmelidir. (Turk J Ophthalmol 2014; 44: 374-8)

🔖

Cite This Article

ÇALIŞ, F., GÜNDÜZ, K., ERDEN, E., KUZU, I. (2022). Clinical findings and treatment results in ocular adnexal lymphomas. Türk Oftalmoloji Dergisi, Cilt: 44 - Sayı: 5, 374–378. https://ajindex.com/articles/630145

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Nutting CM, Jenkins CD, Norton AJ, Cree I, Rose GE, Plowman PN. Primary orbital lymphoma. Hematology J. 2002;3:14-6.
  2. Gündüz K, Esmaeli B. Diagnosis and management of malignant tumors of the eyelids, conjunctiva and orbit. Expert Review Ophthalmology. 2008;3:63-75
  3. Nola M, Lukenda A, Bollmann M, Kalauz M, Petrovecki M, Bollmann R. Outcome and Prognostic factors in ocular adnexal Iymphoma. Croat Med J. 2004;45:328-32.
  4. Knowles DM, Jakobiec FA, McNally L, Burke JS. Lymphoid hyperplasia and malignant lymphoma occurring in the ocular adnexa (orbit, conjunctiva, and eyelids): a prospective multiparametric analysis of 108 cases during 1977 to 1987. Hum Pathol 1990;21:959-73.
  5. Soysal HG, Aköz A, Ardıç F. Orbita ve Oküler Adneks lenfomaları. Turk J Ophthalmol. 2008;38:69-73.
  6. Pazarlı H, Yolar M, Yigitsubay U, Oguz V, Ferhanoglu B. Orbita ve oküler adneks lenfomaları. Turk J Ophthalmol. 2003;33:435-40. Norton AJ. Monoclonal antibodies in the diagnosis of lymphoproliferative diseases of the orbit and orbital adnexae. Eye (Lond). 2006;20:1186-8.
  7. Ferreri AJ, Guidoboni M, Ponzoni M, et al. Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas. J Natl Cancer Inst. 2004;96:586-94. Cohen VM. Treatment options for ocular adnexal lymphoma (OAL). Clin Ophthalmol. 2009;3:689-92.
  8. Chan CC, Smith JA, Shen DF, Ursea R, LeHoang P, Grossniklaus HE. Helicobacter pylori (H.pylori) molecular signature in conjunctival mucosa- associated lymphoid tissue (MALT) lymphoma. Histol Histopathol. 2004;19:1219-26.
  9. Galieni P, Polito E, Leccisotti A, et al. Localized orbital lymphoma. Haematologica. 1997;82:436-9.
  10. Sullivan TJ, Valenzuela AA. Imaging features of ocular adnexal lymphoproliferative disease. Eye (Lond). 2006;20:1189-95.
  11. DePotter P, Shields JA, Shields CL, eds. MRI of the Eye and Orbit. Philadelphia: Lippincott; 1995;245-7.
  12. Gündüz K, Shields CL, Günalp I, Shields JA. Magnetic resonance imaging of unilateral lacrimal gland lesions. Graefes Arch Clin Exp Ophthalmol. 2003;241:907-13.
  13. Valenzuela AA, Allen C, Grimes D, Wong D, Sullivan TJ. Positron emission tomography in the detection and staging of ocular adnexal lymphoproliferative disease. Ophthalmology. 2006;113:2331-7.
  14. Martinet S, Ozsahin M, Belkacemi Y, et al. Outcome and prognostic factors in orbital lymphoma: a Rare Cancer Network study on 90 consecutive patients treated with radiotherapy. Int J Radiat Oncol Biol Phys. 2003;55:892-8.
  15. Woo JM, Tang CK, Rho MS, Lee JH, Kwon HC, Ahn HB. The Clinical characteri